Shire Submits Application To US FDA For Gene Therapy For Hemophilia – Interactive Investor
|
Shire Submits Application To US FDA For Gene Therapy For Hemophilia
Interactive Investor The company said the application, which was based on the results of pre-clinical and phase one studies, to the FDA represented the "latest step forward for Shire's gene therapy program, which shows promise for both hemophilia A and B populations". Shire submits investigational New Drug Application to FDA for Gene … BRIEF-Shire submits IND application for gene therapy candidate SHP654 |
